Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

There is increased risk of developing hypertension in patients with self-reported snoring and excessive daytime sleepiness.

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

There are clinical benefits up to 1 year following endovascular thrombectomy for treatment of acute basilar artery occlusion.

Reduced AMR proportions were noted for multiple pathogens from 2007 to 2019, but some previously declining trends have reversed course since the COVID-19 pandemic.

Hospitalization for COVID-19 represents a coronary artery disease risk equivalent, contributing to an increased risk for MACE.

A study has found that there is a higher prevalence of congenital heart defects and comorbidity burden in Colorado than previously estimated.

Patients are at risk for worse cognition and greater cognitive decline during midlife if they have history of gestational hypertension ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Surgeries are generally safe but cumulatively are associated with cognitive decline and neurodegeneration, according to a study published in the September issue of The Lancet Healthy Longevity.

Time to kidney transplantation can be delayed due to cardiac stress testing, however, stress testing has no effect on mortality risk.